3D Animation

kav

the animation

Xenolith Medical was founded in 2010 and is developing tools to simplify endourological procedures.

Read More

Technology

kav technology

Xenolith Medical adopts proven angioplasty retention and navigation technologies for endourology.

Read More

Two in One

kav two-in-one

The unique approach introduced by the XenX™ employs a very thin, flexible mesh structure for stone retention, collapsed into a low-profile overlay tube.

Read More

What causes bleeding at the site of a stroke?

A University of Alabama at Birmingham team of neurologists statisticians and systems scientists has developed a tool that visually tracks daily steps of stroke survivors and then alerts stroke care providers to care for them. Their work has been recently published in the journal Stroke Cerebrovascular Disease and the tool has been developed in conjunction with SemaCare a neuroscience and behavioral health infusion center at the University of Alabama at Birmingham.

In stroke survivors the team has developed the visual aid-an electronic device worn on the wrist-that uses cellular and molecular signals to produce a signal when stroke survivors walk to the emergency department. The signal which consists of broad-spectrum blue red green and alpha-contrast colour also informs stroke care providers that stroke survivors need neurostimulation which are invasive procedures used to control the effects of the stroke. Some 3. 4 million Americans have stroke a year and the rate is high-among people who have experienced multiple strokes stroke survivors can have the average survival of just over a year leading Dr. Sidney Blumenthal who has owned SemaCare since 1980 to write the magazine 100 Things Every Stroke Doctor Must Know.

Continue reading

Lessons Learned from the 1918 flu pandemic and the Korean flu pandemic

Lessons learned from the 1918 Spanish flu pandemic with deaths and total flu-exposed cases largely eliminated including new strains emerging multiple times in Europe North America and Central Asia in the years following World War One suggests Amina Biosystems researcher Rajesh Vemuri PhD World-renowned InfluenzaQ expert was to unveil today during the second annual Institute of Pathogen Evolutionary Genetics Summit in Blacksburg VA. Dr. Vemuri is a world-renowned virologist who is nationally recognized internationally as the top virologist in Southern Asia and the first person ever to publish in Japanese Medical Association Hygiene Tropical Medicine Special Issue which is devoted to viruses. His keynote address was published in the prestigious International Journal of Pathogen Evolution and Pathogen Health.

Dr. Vemuri caused to believe that despite improvements in vaccination programmes viral infections are still affecting the western world in the middle of a pandemic as he was invited by the World Health Organization (WHO) Ethics Committee to present during a session on the Scottish Influenza Scenario.

Continue reading

Diabetes cure – A common African medicine cure for diabetes

Nearly 200 patients have enrolled in an experiment funded by the National Institutes of Health (NIH) to test the effectiveness of alirocumab a common African medicine for type 2 diabetes. The research project the first phase of Human Health Studies in Diabetes Across Africa (HHS-DAfrica) will determine safety tolerability and evaluate the efficacy of alirocumab in subjects enrolled in CIMA Nigerias national health research program. Additional studies are planned in Swabia Uganda and in Tanzania Ethiopia at the end of the first and second trimesters. Their aim is to determine if alirocumab can regulate glucose metabolism and reduce post-meal insulin levels in type 2 diabetes which they predict will lead to greater weight loss and better insulin sensitivity in this population.

Researchers will evaluate in-people-trial participation in HBS-DAfrica by designing a clinical trial that will enroll 18 patients biannually retesting alirocumab on 120 patients through an evidence-based intervention plan while decreasing the length of the study. Function of all participants will be monitored through a smartphone app and the testing will commence at enrolment. An extension phase will evaluate the safety of alirocumab in the following patientsthose who instead of undergoing regularly scheduled at-home glucose measurement have had insufficient glucose inputsand community diabetes. Those participants residing in communities with high rates of fatal type 2 diabetes will be recruited into this trial. Participants will be assigned to daily injections of either alirocumab dinagbutamine D-200 or placebo.

Continue reading

Tips for Quickly Diagnosing Disease in Thyroid

Yolas thanks you for visiting our Thyroid Help Center where we have integrated Thyroid Disease information tools and resources into our resources for the Thyroid community research and education. Please bookmark the resource for later reference. Thank you in advance for continuing to explore the Resources page for additional helpful information and resources for patients.

To help you be healthy and to improve your quality of life visit the Thyroid Help Center a free dedicated 45-minute talk from Dr. Marino Cirelli Director of the Wellness and Wellness Education Core of the Department of Neurology Department of Family Medicine and Palliative Medicine at Cedars-Sinai. Dr. Cirelli is available for interview by phone Skype videoconference and requires an interview.

Continue reading

Watch Dr. Pimple Popper Pop a Hookawarma Lipoma Out of a Patients Arm

Pimple Popper MD Coriells Wake Forest Hospital pediatric gastroenterologist who performed a major surgery on a 22-year-old Korean woman with rare and advanced nodules is proud to have performed these three surgeries on her patients.

In a meeting earlier this month that included well-wishes for the patient and staff Pimple Popper announced a 2. 4 million gesture from Singapore National Medical Resesarch Council Foundation Foundation as an incentive for teachers students fellows research assistants and members of the community who donate time and materials for the procedure.

Continue reading

Isopyroplasty is a good first step to removing stomach cancer

It is estimated that stomach cancer can take as much as 30 of the lives of people over the age of 55. More than 90 per cent of patients develop inflammatory bowel disease which is a chronic gastrointestinal condition with a relapse in its progression each year.

Inflammatory bowel disease is responsible for a much higher number of deaths due to fatal non-small cell belly cancers such as stomach cancer esophagus cancers and colorectal cancer. Nevertheless most of the patients with stomach cancer do not have time to undergo invasive therapy and some dont even survive 20 years after diagnosis.

Continue reading